hotspot -WSS

hotspot

author：comprehensive 2025-09-30 00:49:19 - browse：47471

Human embryonic stem cells Annie Cavanagh/Wellcome Images

The Food and Drug Administration on Thursday unveiled a series of guidelines that aim to encourage the development of promising and legitimate stem cell therapies while distinguishing them from the largely untested stem cell treatments hawked by unregulated clinics around the country.

The FDA’s guidelines have been expected and eagerly awaited by the stem cell community given the rapid proliferation of untested — and potentially unsafe — therapies around the country. Clinics promoting these therapies claim to be able to treat ailments from autism to neurodegenerative disorders to erectile dysfunction.

The guidelines also spell out how the agency will implement the regenerative medicine provisions in a behemoth law enacted last year called the 21st Century Cures Act.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Teladoc has a new CEO, but challenges remain the same

WSS

Tesla recalling nearly 16,000 of its 2021

Moderna says combo Covid

Driven by the pandemic, applicants flood public health schools

Curing rare childhood diseases will falter unless Congress steps up

Driven by the pandemic, applicants flood public health schools

ALS patient reclaims some autonomy thanks to wearable 'robot'

explore

hotspot

focus

Novavax promises a turnaround & Lilly roils the obesity market

A Q&A with Gavi’s Seth Berkley on vaccines, Covid, and more

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

'Stay indoors': Escaped wild animal on the loose in Berlin prompts urgent citywide search

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Stephen Quake on the Chan Zuckerberg quest to conquer disease

Anesthesiologist group: stop taking Ozempic before surgery

Statins may not be needed by millions of people, study suggests

In age of alternative facts, a scholarly course on calling out crap

Medical device trials still don't enroll enough women, study finds

knowledge

Mass General totes up its waste in a move to tackle climate change

Pharma companies must ensure equitable access to obesity drugs

Teladoc has a new CEO, but challenges remain the same

Stanford president's case begs question: Who takes blame?

California wildfire smoke linked to 52,000 early deaths, study says

A Q&A with Gavi’s Seth Berkley on vaccines, Covid, and more

focus

explore

explore

focus